Starpharma completes A$15 million raising

Starpharma completes A$15 million raising
Biotech Intelligence (press release), France - Dec 20, 2005 The Company s lead development product is VivaGel , a vaginal microbicide designed to prevent the transmission of STIs, including HIV and genital herpes.

South Africa's Good News on AIDS
American Enterprise Institute, DC - Dec 20, 2005 is a cheap prophylactic anti-viral drug called acyclovir that can prevent Herpes. A few of the women have had vaginal irritation resulting from the gel

Herpes